Skip to content

Principal Investigators

David A. Alagpulinsa, PhD

Principal Investigator

Dr. Alagpulinsa is a Research Fellow in Medicine at the Massachusetts General Hospital Vaccine and Immunotherapy Center and Harvard Medical School. Dr. Alagpulinsa is a trained pharmacist, pharmacologist and interdisciplinary biomedical scientist.

Huabiao Chen, PhD

Principal Investigator

Dr. Chen joined VIC in 2015 with a focus on mesenchymal stem/stromal cells (MSCs) and MSC-derived intracellular vesicles/exosomes for therapy of various cancers. He is actively involved in the preclinical development of vaccines and immunotherapies for cancer by regrouping and redirecting immune responses in the tumor microenvironment to combat cancer.

Tianhong Dai, PhD

Principal Investigator

Dr. Dai is an Associate Member of VIC. His current research is focused on developing light-based technologies for preventing and treating infectious diseases. Particularly, he is considered a world leader who is responsible for launching the new research area of antimicrobial blue light therapy for multidrug-resistant infections.

Ruxandra F. Sîrbulescu, PhD

Principal Investigator

Dr. Ruxandra Sîrbulescu is a Principal Investigator in the Vaccine and
Immunotherapy Center, Instructor in Investigation at Massachusetts General
Hospital, and Instructor of Medicine at Harvard Medical School. Dr. Sîrbulescu is
a trained neurobiologist whose research interests focus on regenerative